首页> 外国专利> TITRATION PACKAGE FOR NERAMEXANE AND ITS USE IN THE TREATMENT OF INNER EAR DISORDER

TITRATION PACKAGE FOR NERAMEXANE AND ITS USE IN THE TREATMENT OF INNER EAR DISORDER

机译:Neramexane滴定液及其在内耳疾病治疗中的应用。

摘要

PROBLEM TO BE SOLVED: To provide a titration scheme for administration of a 1-amino-alkylcyclohexane derivative for the treatment of an inner ear disorder such as tinnitus and hearing loss while minimizing side effects.SOLUTION: This invention relates to use of neramexane (1-amino-1,3,3,5,5-pentamethylcyclohexane) and pharmacologically acceptable salt thereof (e.g., neramexane mesylate) as a 1-amino-alkylcyclohexane derivative, wherein the use is for medicament production for administration based on a titration scheme including up-titration of the medicament by increasing the dose by 25 mg or 12.5 mg per week to achieve an effective dose of 50-75 mg/day.
机译:解决的问题:提供一种滴定方案,用于给药1-氨基-烷基环己烷衍生物以治疗内耳疾病,如耳鸣和听力损失,同时将副作用降至最低。解决方案:本发明涉及奈拉美生(1 -氨基-1,3,3,5,5-五甲基环己烷)及其药理学上可接受的盐(例如甲磺酸奈拉美生)为1-氨基-烷基环己烷衍生物,其中该用途用于基于滴定方案的药物生产,包括通过每周增加25 mg或12.5 mg的剂量来增加药物的滴定度,以达到50-75 mg /天的有效剂量。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号